| SC 13D/A | 2024-04-17 | Fortress Biotech, Inc. | AVENUE THERAPEUTICS, INC. | 3,564,059 | 8.0% | EDGAR |
| SC 13G/A | 2024-01-02 | SABBY MANAGEMENT, LLC | AVENUE THERAPEUTICS, INC. | 661,056 | 5.0% | EDGAR |
| SC 13G/A | 2023-12-13 | Davidow Robert L | AVENUE THERAPEUTICS, INC. | 1,309,800 | 9.9% | EDGAR |
| SC 13G | 2023-11-28 | Davidow Robert L | AVENUE THERAPEUTICS, INC. | 1,926,800 | 14.5% | EDGAR |
| SC 13D/A | 2023-09-18 | Fortress Biotech, Inc. | AVENUE THERAPEUTICS, INC. | 1,049,056 | 12.1% | EDGAR |
| SC 13G/A | 2023-02-14 | CVI Investments, Inc. | AVENUE THERAPEUTICS, INC. | 251,011 | 4.9% | EDGAR |
| SC 13D/A | 2023-01-06 | Fortress Biotech, Inc. | AVENUE THERAPEUTICS, INC. | 578,227 | 11.3% | EDGAR |
| SC 13G | 2023-01-04 | SABBY MANAGEMENT, LLC | AVENUE THERAPEUTICS, INC. | 264,000 | 5.5% | EDGAR |
| SC 13G/A | 2022-12-14 | Nantahala Capital Management, LLC | AVENUE THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-10-19 | InvaGen Pharmaceuticals, Inc. | AVENUE THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-10-17 | CVI Investments, Inc. | AVENUE THERAPEUTICS, INC. | 272,700 | 6.6% | EDGAR |
| SC 13G | 2022-10-17 | INTRACOASTAL CAPITAL, LLC | AVENUE THERAPEUTICS, INC. | - | - | EDGAR |
| SC 13D/A | 2022-07-28 | InvaGen Pharmaceuticals, Inc. | AVENUE THERAPEUTICS, INC. | 10,660,228 | 47.0% | EDGAR |
| SC 13G | 2022-02-14 | Nantahala Capital Management, LLC | AVENUE THERAPEUTICS, INC. | 1,453,166 | 7.7% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | AVENUE THERAPEUTICS, INC. | 452,653 | 2.4% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD INDEX FUNDS | AVENUE THERAPEUTICS, INC. | 452,653 | 2.4% | EDGAR |
| SC 13G/A | 2021-02-12 | Opaleye Management Inc. | AVENUE THERAPEUTICS, INC. | 9 | 11.0% | EDGAR |
| SC 13G | 2021-02-10 | VANGUARD GROUP INC | AVENUE THERAPEUTICS, INC. | 939,706 | 5.6% | EDGAR |
| SC 13G | 2021-02-08 | VANGUARD INDEX FUNDS | AVENUE THERAPEUTICS, INC. | 838,827 | 5.0% | EDGAR |
| SC 13G/A | 2020-02-14 | Opaleye Management Inc. | AVENUE THERAPEUTICS, INC. | 9 | 11.0% | EDGAR |